NFKB1 and thyroid gland carcinoma: Unfortunately, in some cases, the antitumoral inefficacy of NF-κB inactivation in thyroid cancer cells has been proven, as well as the failure of NF-κB inhibition to improve the therapeutic effects of antineoplastic drugs.